CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 447 enrolled
Drug / intervention
ILLUMISITE™ Platform (EMN bronchoscopy) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05705544
NCT05705544N/ACompleted
CompareCT.gov

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)

Vanderbilt University Medical Center·interventional·Posted Jan 30, 2023·Updated Apr 24, 2025

In Brief

A clinical study evaluating ILLUMISITE™ Platform (EMN bronchoscopy) and Ion™ Endoluminal System (SSCB bronchoscopy) for Peripheral Pulmonary Lesions. Completed, enrolled 447 participants across 1 site.

Detailed Summary

This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Pulmonary Lesions
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 30, 2023
Enrollment StartMar 6, 2023
Primary CompletionApr 9, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.4 years ago

Interventions

ILLUMISITE™ Platform (EMN bronchoscopy)device

Providers will utilize the ILLUMISITE™ Platform (EMN) machine to perform a diagnostic bronchoscopy procedure.

Ion™ Endoluminal System (SSCB bronchoscopy)device

Providers will utilize the Ion™ Endoluminal System (SSCB) machine to perform a diagnostic bronchoscopy procedure.